Meet us
Current Presentations
|
Presentation German Equity Forum November 2025 | |
|
R&D Webinar November 2025 - Replay: The Evolution of Amanitin ADCs: Insights from HDP-101 | |
|
Presentation World ADC November 2025 | |
|
Webcast "Strategic Focusing" as of 25 September 2025 | |
|
Presentation: Strategic and operational focusing | |
|
IMS - International Myeloma Society Annual Meeting | |
|
R&D Webinar June 2025 - Replay: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC |
Upcoming Conferences 2025
Past Conferences 2025
| Event | Date | Location | Link |
|---|---|---|---|
|
Deutsches Eigenkapitalforum
|
24. - 26. November
|
Frankfurt
| |
|
BIO-Europe
|
3. - 5. November
|
Wien
| |
|
Annual World ADC San Diego 2025
|
3. - 6. November
|
San Diego
| |
|
BioJapan
|
8. - 10. Oktober
|
Yokohama
| |
|
IMS - International Myeloma Society Annual Meeting
|
17. - 20. September
|
Toronto
| |
|
ADC & Novel Conjugates Partnering & Investment Summit
|
9. - 10. September
|
Boston
| |
|
The Antibody Series 2025
|
9. - 12. September
|
Porto
| |
|
ADC Linker & Conjugation Summit
|
19. - 21. August
|
Boston
| |
|
ADC Toxicity Summit
|
8. - 10. Juli
|
Boston
| |
|
Webinar: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC
|
17. Juni, 5 pm CEST
| ||
|
Bio International Convention
|
16. - 19. Juni
|
Boston
| |
|
Zacks SCR Life Sciences Investor Forum
|
12. Juni
| ||
|
EHA Annual Congress
|
12. - 15. Juni
|
Mailand
| |
|
World ADC Asia Congress
|
10. - 12. Juni
|
Seoul
| |
|
2025 ASCO Annual Meeting
|
30. Mai - 3. Juni
|
Chicago
|
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.